Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study.

Tayoshi S, Nakataki M, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Ueno S, Harada M, Ohmori T.

Schizophr Res. 2010 Mar;117(1):83-91. doi: 10.1016/j.schres.2009.11.011. Epub 2009 Dec 22.

PMID:
20022731
[PubMed - indexed for MEDLINE]
2.

Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).

Tayoshi S, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Nakataki M, Ueno S, Harada M, Ohmori T.

Schizophr Res. 2009 Mar;108(1-3):69-77. doi: 10.1016/j.schres.2008.11.014. Epub 2008 Dec 20.

PMID:
19097753
[PubMed - indexed for MEDLINE]
3.

Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study.

Ham BJ, Sung Y, Kim N, Kim SJ, Kim JE, Kim DJ, Lee JY, Kim JH, Yoon SJ, Lyoo IK.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):403-11. Epub 2006 Dec 1.

PMID:
17141385
[PubMed - indexed for MEDLINE]
4.

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC.

Arch Gen Psychiatry. 2012 May;69(5):449-59. doi: 10.1001/archgenpsychiatry.2011.1519. Epub 2012 Jan 2.

PMID:
22213769
[PubMed - indexed for MEDLINE]
5.

N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.

Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, Poplawska R, Tomczak AA, Czernikiewicz A, Walecki J.

Med Sci Monit. 2007 May;13 Suppl 1:17-22.

PMID:
17507880
[PubMed - indexed for MEDLINE]
6.
7.

Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.

Goto N, Yoshimura R, Moriya J, Kakeda S, Ueda N, Ikenouchi-Sugita A, Umene-Nakano W, Hayashi K, Oonari N, Korogi Y, Nakamura J.

Schizophr Res. 2009 Jul;112(1-3):192-3. doi: 10.1016/j.schres.2009.04.026. Epub 2009 May 21. No abstract available.

PMID:
19464152
[PubMed - indexed for MEDLINE]
8.

Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.

Jessen F, Scherk H, Träber F, Theyson S, Berning J, Tepest R, Falkai P, Schild HH, Maier W, Wagner M, Block W.

Schizophr Res. 2006 Oct;87(1-3):81-8. Epub 2006 Jul 13.

PMID:
16842971
[PubMed - indexed for MEDLINE]
9.

Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.

Bustillo JR, Rowland LM, Jung R, Brooks WM, Qualls C, Hammond R, Hart B, Lauriello J.

Neuropsychopharmacology. 2008 Sep;33(10):2456-66. Epub 2007 Dec 19.

PMID:
18094668
[PubMed - indexed for MEDLINE]
Free Article
10.

Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.

Yoo SY, Yeon S, Choi CH, Kang DH, Lee JM, Shin NY, Jung WH, Choi JS, Jang DP, Kwon JS.

Schizophr Res. 2009 Jun;111(1-3):86-93. doi: 10.1016/j.schres.2009.03.036. Epub 2009 Apr 29.

PMID:
19406622
[PubMed - indexed for MEDLINE]
11.

Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.

Heimberg C, Komoroski RA, Lawson WB, Cardwell D, Karson CN.

Psychiatry Res. 1998 Aug 26;83(2):105-15.

PMID:
9818736
[PubMed - indexed for MEDLINE]
12.

Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study.

Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA.

Pharmacopsychiatry. 2001 Nov;34(6):251-3.

PMID:
11778146
[PubMed - indexed for MEDLINE]
13.

Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy.

Shibuya-Tayoshi S, Tayoshi S, Sumitani S, Ueno S, Harada M, Ohmori T.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):249-56. Epub 2007 Aug 22.

PMID:
17913322
[PubMed - indexed for MEDLINE]
14.

Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.

Tomelleri L, Jogia J, Perlini C, Bellani M, Ferro A, Rambaldelli G, Tansella M, Frangou S, Brambilla P; Neuroimaging Network of the ECNP networks initiative.

Eur Neuropsychopharmacol. 2009 Dec;19(12):835-40. doi: 10.1016/j.euroneuro.2009.07.007. Epub 2009 Aug 29.

PMID:
19717283
[PubMed - indexed for MEDLINE]
15.

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Théberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, Schaefer B, Densmore M, Drost DJ.

Am J Psychiatry. 2003 Dec;160(12):2231-3.

PMID:
14638596
[PubMed - indexed for MEDLINE]
16.

Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.

Qi LY, Xiu MH, Chen da C, Wang F, Kosten TA, Kosten TR, Zhang XY.

Neurosci Lett. 2009 Sep 22;462(2):113-7. doi: 10.1016/j.neulet.2009.06.019. Epub 2009 Jun 17.

PMID:
19539717
[PubMed - indexed for MEDLINE]
17.

Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy.

Choe BY, Suh TS, Shinn KS, Lee CW, Lee C, Paik IH.

Invest Radiol. 1996 Jun;31(6):345-52.

PMID:
8761867
[PubMed - indexed for MEDLINE]
18.

Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.

Snitz BE, MacDonald A 3rd, Cohen JD, Cho RY, Becker T, Carter CS.

Am J Psychiatry. 2005 Dec;162(12):2322-9.

PMID:
16330597
[PubMed - indexed for MEDLINE]
19.

Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine.

Khorram B, Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Goghari VM, Smith GN, Honer WG.

Am J Psychiatry. 2006 Nov;163(11):2005-7. Erratum in: Am J Psychiatry. 2006 Dec;163(12):2199.

PMID:
17074955
[PubMed - indexed for MEDLINE]
20.

Elevated gamma-aminobutyric acid levels in chronic schizophrenia.

Ongür D, Prescot AP, McCarthy J, Cohen BM, Renshaw PF.

Biol Psychiatry. 2010 Oct 1;68(7):667-70. doi: 10.1016/j.biopsych.2010.05.016. Epub 2010 Jul 2.

PMID:
20598290
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk